• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Oligodendroglial Alpha-Synuclein Rewires Midbrain Gene Programs Before Nigral Cell Loss in Mouse Model of MSA

by
October 28, 2026
in Biology, Health
Reading Time: 3 mins read
0
Oligodendroglial Alpha-Synuclein Rewires Midbrain Gene Programs Before Nigral Cell Loss in Mouse Model of MSA

Oligodendroglial Alpha-Synuclein Rewires Midbrain Gene Programs Before Nigral Cell Loss in Mouse Model of MSA

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Multiple system atrophy (MSA) is a progressive neurodegenerative disease defined by the accumulation of alpha-synuclein protein inside oligodendrocytes, the myelin-forming cells of the central nervous system, together with selective degeneration of the striatonigral and olivopontocerebellar systems. Why certain brain regions succumb while others resist for longer has remained an open question, and a new study in Cellular and Molecular Neurobiology addresses it by mapping gene-expression changes in a mouse model of the disease.

Researchers led by Antonio Heras-Garvin, Sarah Wilhelmer, Galina Apostolova, Gregor K. Wenning and Nadia Stefanova used the PLP-alphaSyn mouse model, in which alpha-synuclein is expressed in oligodendrocytes. The model reproduces key features of human MSA, showing progressive striatonigral degeneration and later cerebellar involvement, making it a suitable platform for asking when and where molecular changes appear relative to visible neuronal loss.

The team performed bulk RNA sequencing of ventral midbrain tissue, including the substantia nigra, from PLP-alphaSyn mice and wildtype controls at two ages: 2 months and 12 months. The earlier time point was chosen because it precedes overt dopaminergic neuronal loss, allowing the investigators to test whether transcriptional disruption precedes detectable degeneration.

The results show that it does. At 2 months, before any overt loss of dopaminergic neurons, the ventral midbrain of PLP-alphaSyn mice already displayed marked dysregulation. Programs related to RNA processing and synaptic function were increased, while pathways governing mitochondrial function, metabolism and myelin maintenance were reduced.

By 12 months of age, these alterations had persisted and deepened. The older mice showed stronger suppression of oxidative phosphorylation, mitochondrial inner membrane and respiratory-chain complexes, fatty-acid and lipid metabolism, and myelin maintenance. In other words, the bioenergetic and oligodendroglial-support deficits were not a transient early response but a progressive transcriptional signature that tracked the advancing disease.

To probe regional vulnerability directly, the researchers compared these ventral midbrain findings with cerebellar transcriptomic data from the same model. The comparison revealed a clear temporal and spatial pattern: mitochondrial and myelin-related impairments emerged earlier and more strongly in the ventral midbrain than in the cerebellum, where related signatures became more evident only at later disease stages.

The authors emphasize that the findings identify early and progressive transcriptional dysregulation of bioenergetic, metabolic and oligodendroglial and myelin-support programs in experimental MSA, and highlight these processes as candidate contributors to regional vulnerability in this model.

Several caveats frame the work. The study was conducted in a transgenic mouse model rather than human tissue, and bulk RNA sequencing averages signals across mixed cell populations, so cell-type-specific contributions cannot be resolved from these data alone. The findings are associations between oligodendroglial alpha-synucleinopathy and transcriptional states, not demonstrations of causal mechanisms, and the paper is being shared early as a peer-reviewed, accepted version subject to further edits before the final Version of Record.

Even with those limitations, the study offers a molecular timetable for MSA-like pathology: energy metabolism and myelin-support programs falter in the ventral midbrain long before neurons die, and the same deficits arrive late in the comparatively spared cerebellum.

Subject of Research: Transcriptional changes linked to oligodendroglial alpha-synucleinopathy and regional nigral vulnerability in a mouse model of multiple system atrophy.

Article Title: Oligodendroglial α-Synucleinopathy Remodels Transcriptional Programs Associated with Nigral Vulnerability in Experimental Multiple System Atrophy

Article References: Heras-Garvin, A., Wilhelmer, S., Apostolova, G., Wenning, G. K., & Stefanova, N. (2026). Oligodendroglial α-Synucleinopathy Remodels Transcriptional Programs Associated with Nigral Vulnerability in Experimental Multiple System Atrophy. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-026-01839-y

Image Credits: AI Generated

DOI: 10.1007/s10571-026-01839-y

Keywords: multiple system atrophy, alpha-synuclein, oligodendrocytes, substantia nigra, RNA sequencing, mitochondrial dysfunction, myelin, PLP-alphaSyn mouse model, neurodegeneration, regional vulnerability, oxidative phosphorylation, cerebellum

News Source: Juliet Wilcox. (October 28, 2026). Oligodendroglial Alpha-Synuclein Rewires Midbrain Gene Programs Before Nigral Cell Loss in Mouse Model of MSA. Scienmag.

Tags: Alpha-synucleincerebellumMitochondrial dysfunctionmultiple system atrophymyelinneurodegenerationoligodendrocytesoxidative phosphorylationPLP-alphaSyn mouse modelregional vulnerabilityRNA sequencingsubstantia nigra
Share12Tweet7Share2ShareShareShare1

Related Posts

Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

October 28, 2026
Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

October 28, 2026

FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia

October 28, 2026

Regulators, developers and clinicians in Shenzhen voice concerns over medical AI governance

October 28, 2026

POPULAR NEWS

  • Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

    Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

    29 shares
    Share 12 Tweet 7
  • Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

    29 shares
    Share 12 Tweet 7
  • FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia

    29 shares
    Share 12 Tweet 7
  • Regulators, developers and clinicians in Shenzhen voice concerns over medical AI governance

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.